297 related articles for article (PubMed ID: 22428467)
1. Hypoglycemic effect and mechanism of a proteoglycan from ganoderma lucidum on streptozotocin-induced type 2 diabetic rats.
Teng BS; Wang CD; Zhang D; Wu JS; Pan D; Pan LF; Yang HJ; Zhou P
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):166-75. PubMed ID: 22428467
[TBL] [Abstract][Full Text] [Related]
2. Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice.
Wang CD; Teng BS; He YM; Wu JS; Pan D; Pan LF; Zhang D; Fan ZH; Yang HJ; Zhou P
Br J Nutr; 2012 Dec; 108(11):2014-25. PubMed ID: 22453054
[TBL] [Abstract][Full Text] [Related]
3. A protein tyrosine phosphatase 1B activity inhibitor from the fruiting bodies of Ganoderma lucidum (Fr.) Karst and its hypoglycemic potency on streptozotocin-induced type 2 diabetic mice.
Teng BS; Wang CD; Yang HJ; Wu JS; Zhang D; Zheng M; Fan ZH; Pan D; Zhou P
J Agric Food Chem; 2011 Jun; 59(12):6492-500. PubMed ID: 21585203
[TBL] [Abstract][Full Text] [Related]
4. A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway.
Yang Z; Wu F; He Y; Zhang Q; Zhang Y; Zhou G; Yang H; Zhou P
Food Funct; 2018 Jan; 9(1):397-406. PubMed ID: 29215104
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B.
Wu Y; Ou-Yang JP; Wu K; Wang Y; Zhou YF; Wen CY
Acta Pharmacol Sin; 2005 Mar; 26(3):345-52. PubMed ID: 15715932
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization and bioactivity evaluation of an acidic proteoglycan extract from Ganoderma lucidum fruiting bodies for PTP1B inhibition and anti-diabetes.
Pan D; Wang L; Hu B; Zhou P
Biopolymers; 2014 Jun; 101(6):613-23. PubMed ID: 24127303
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats.
Wu Y; Ouyang JP; Wu K; Wang SS; Wen CY; Xia ZY
Br J Pharmacol; 2005 Sep; 146(2):234-43. PubMed ID: 15997237
[TBL] [Abstract][Full Text] [Related]
9. [Effects of different compatibility proportion of jiaotai pills on treating type 2 diabetes mellitus in rats].
Wang J; Lu F; Dong H; Gong Y; Xu L; Zou X; Chen G
Zhongguo Zhong Yao Za Zhi; 2011 Aug; 36(16):2271-6. PubMed ID: 22097345
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism.
Pan D; Zhang D; Wu J; Chen C; Xu Z; Yang H; Zhou P
PLoS One; 2013; 8(7):e68332. PubMed ID: 23874589
[TBL] [Abstract][Full Text] [Related]
11. A novel proteoglycan from Ganoderma lucidum fruiting bodies protects kidney function and ameliorates diabetic nephropathy via its antioxidant activity in C57BL/6 db/db mice.
Pan D; Zhang D; Wu J; Chen C; Xu Z; Yang H; Zhou P
Food Chem Toxicol; 2014 Jan; 63():111-8. PubMed ID: 24211521
[TBL] [Abstract][Full Text] [Related]
12. Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice.
Xiao C; Wu QP; Cai W; Tan JB; Yang XB; Zhang JM
Arch Pharm Res; 2012 Oct; 35(10):1793-801. PubMed ID: 23139131
[TBL] [Abstract][Full Text] [Related]
13. Effect of N-benzoyl-D-phenylalanine on streptozotocin-induced changes in the lipid and lipoprotein profile in rats.
Ashokkumar N; Pari L; Manimekalai A; Selvaraju K
J Pharm Pharmacol; 2005 Mar; 57(3):359-66. PubMed ID: 15807992
[TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
[TBL] [Abstract][Full Text] [Related]
15. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
Abdin AA; Baalash AA; Hamooda HE
J Diabetes Complications; 2010; 24(3):168-78. PubMed ID: 19328014
[TBL] [Abstract][Full Text] [Related]
16. [Study on the mechanism of action of total flavonoids of Litsea coreana for reducing blood glucose level in rat with type 2 diabetes mellitus].
Sun YX; Lu YX; Wang LY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):617-21. PubMed ID: 20815278
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic effect of Symplocos cochinchinensis (Lour.) S. Moore. in type 2 diabetic rats.
Sunil C; Ignacimuthu S; Agastian P
J Ethnopharmacol; 2011 Mar; 134(2):298-304. PubMed ID: 21182925
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes.
Rajasekaran S; Ravi K; Sivagnanam K; Subramanian S
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):232-7. PubMed ID: 16487267
[TBL] [Abstract][Full Text] [Related]
19. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic activity of Ganoderma lucidum polysaccharides F31 down-regulated hepatic glucose regulatory enzymes in diabetic mice.
Xiao C; Wu Q; Zhang J; Xie Y; Cai W; Tan J
J Ethnopharmacol; 2017 Jan; 196():47-57. PubMed ID: 27902927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
